Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
Why the study?
Does pharmacomechanical catheter-directed thrombolysis reduce the risk of post-thrombotic syndrome in patients with proximal deep-vein thrombosis?
Population
Patients with proximal deep-vein thrombosis
Authors
Discussion
Loading...
Member takes
Implication
Should not change DVT practice; leaves open whether pharmacomechanical thrombolysis reduces post-thrombotic syndrome.
Structured PICO
Does pharmacomechanical catheter-directed thrombolysis reduce the risk of post-thrombotic syndrome in patients with proximal deep-vein thrombosis?
P
Population
Patients with proximal deep-vein thrombosis
I
Intervention
Pharmacomechanical catheter-directed thrombolysis
O
Outcome
Post-thrombotic syndrome
Pharmacomechanical catheter-directed thrombolysis is hypothesized to reduce the risk of post-thrombotic syndrome in patients with proximal deep-vein thrombosis.
Cite This Study
Vedantham et al. (2017) studied this question.